HLA-A*03 may confer protection against long COVID through an enhanced immune response
Eduardo Pons-Fuster(Universidad de Murcia), Enrique Bernal(Hospital Reina Sofía de Murcia), Inmaculada Ruiz-Lorente(Instituto Murciano de Investigación Biosanitaria), Marta Moreno(Hospital General Universitario Morales Meseguer), José María Pérez Gómez(Hospital General Universitario Morales Meseguer), Elisa Ma Sahún García(Instituto Murciano de Investigación Biosanitaria), Alfredo Minguela, María V. Martínez‐Sánchez(Instituto Murciano de Investigación Biosanitaria), Ana Peláez(Hospital Rafael Méndez), Ángeles Muñoz(Hospital Universitario Reina Sofía), Cristina Tomás(Hospital Reina Sofía de Murcia), Rodrigo Martínez-Rodríguez(Hospital Reina Sofía de Murcia), Diana Ceballos‐Francisco(Instituto Murciano de Investigación Biosanitaria), Lourdes Gimeno-Arias(Instituto Murciano de Investigación Biosanitaria), María José Alcaraz García(Jewish General Hospital)
Cited by 1
Related Papers
Low-Level Viremia Is Associated With Clinical Progression in HIV-Infected Patients Receiving Antiretroviral Treatment
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2018|80
Dual RNA-seq identifies human mucosal immunity protein Mucin-13 as a hallmark of Plasmodium exoerythrocytic infection
|Nature Communications|2019|76
IL-4 Up-Regulates MiR-21 and the MiRNAs Hosted in the CLCN5 Gene in Chronic Lymphocytic Leukemia
|PLoS ONE|2015|49
Dock10, a novel CZH protein selectively induced by interleukin-4 in human B lymphocytes
|Molecular Immunology|2008|46
Circulating MR-proADM levels, as an indicator of endothelial dysfunction, for early risk stratification of mid-term mortality in COVID-19 patients
|International Journal of Infectious Diseases|2021|42